Advertisement

6-Ketocholestanol suppresses lipid accumulation by decreasing FASN gene expression through SREBP-dependent regulation in HepG2 cells

  • Bungo Shirouchi
  • Shuhei Yanagi
  • Chinami Okawa
  • Maiko Koga
  • Masao SatoEmail author
Original Paper
  • 12 Downloads

Abstract

Nuclear receptors, such as liver X receptors (LXRs) and sterol regulatory element-binding proteins (SREBPs), are key regulators of lipogenic genes, including fatty acid synthase (FASN). It has been reported that several oxycholesterols (OCs) act as LXR ligands; however, it is unclear whether all OC molecular species act as ligands. We previously demonstrated that the absorption rate of dietary 6-ketocholestanol (6-keto), an oxycholesterol, is the highest of all the OCs using thoracic lymph duct-cannulated rats. However, limited information is available about the physiological significance of 6-keto. In this study, we investigated whether treatment with 6-keto increases intracellular triacylglycerol (TAG) levels through up-regulation of lipogenic gene expression in HepG2 cells. 6-Keto treatment significantly reduced intracellular TAG levels through down-regulation of lipogenic genes including FASN. Although 6-keto significantly suppressed FASN gene promoter activities, the action was completely diminished when mutations were present in the SREBP promoter site. TO901317 (TO) significantly increased FASN gene promoter activities, whereas simultaneous treatment with TO and 6-keto significantly reduced this activity. We also compared the effects of several OCs that are oxidized at the carbon-6 and -7 in the B-ring of cholesterol on FASN gene promoter activities. Similar to 6-keto, 6α-OH and 6β-OH significantly reduced the activity of the FASN gene promoter, which suggests that oxidation of carbon-6 in the B-ring may play an important role in the reduction of FASN expression. Our results indicate that 6-keto suppresses lipid accumulation by decreasing FASN gene expression through SREBP-dependent regulation in HepG2 cells.

Keywords

6-Ketocholestanol Fatty acid synthase SREBP Lipid accumulation HepG2 cell 

Notes

Acknowledgements

This work was supported by JSPS KAKENHI Grant Number 21580144. The authors thank Editage (www.editage.jp) for English language editing.

Author contributions

BS wrote the manuscript. SY, CO, and MK participated in the experimental work and collected and analyzed data. BS and MS contributed to the study design, supervised the study, and commented on the manuscript. All authors have read and approved the final version of the manuscript.

Compliance with ethical standards

Conflict of interests

The authors declare that they have no conflict of interests.

Supplementary material

10616_2019_368_MOESM1_ESM.pptx (53 kb)
Supplemental Fig. 1. The sequence of the human FASN promoter region. Underlines indicate selected regulatory elements. LXRE, liver X receptor response element; SRE, sterol response element; SREBP, sterol regulatory element-binding protein. Supplemental Fig. 2. The sequences of wild type and mutant LXRE and SREBP elements from the rat Fasn promoter region. Underlines indicate selected regulatory elements. Dotted bases indicate mutations in the LXRE and SREBP elements. LXRE, liver X receptor response element; SRE, sterol response element; SREBP, sterol regulatory element-binding protein. (PPTX 52 kb)

References

  1. Bai Q, Xu L, Kakiyama G, Runge-Morris MA, Hylemon PB, Yin L, Pandak WM, Ren S (2011) Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Atherosclerosis 214:350–356CrossRefGoogle Scholar
  2. Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331–340CrossRefGoogle Scholar
  3. Chirgwin JM, Przbyla AE, McDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299CrossRefGoogle Scholar
  4. Cuéllar A, Ramirez J, Infante VM, Chavez E (1997) Further studies on the recoupling effect of 6-ketocholestanol upon oxidative phosphorylation in uncoupled liver mitochondria. FEBS Lett 411:365–368CrossRefGoogle Scholar
  5. Emanuel HA, Hassel CA, Addis PB, Bergmann SD, Zavoral JH (1991) Plasma cholesterol oxidation products in human subjects fed a meal rich in oxysterols. J Food Sci 56:843–847CrossRefGoogle Scholar
  6. Goldstein JL, DeBose-Boyd RA, Brown MS (2006) Protein sensors for membrane sterols. Cell 124:35–46CrossRefGoogle Scholar
  7. Ichi I, Iwamoto M, Tomoyori H, Sato M, Ikeda I, Imaizumi K (2005) Intake of oxycholesterols and oxyphytosterols in Japanese meals. J Jpn Soc Nutr Food Sci 58:145–149 (Article in Japanese) CrossRefGoogle Scholar
  8. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728–731CrossRefGoogle Scholar
  9. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, Collins JL, Osborne TF, Tontonoz P (2002) Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 277:11019–11025CrossRefGoogle Scholar
  10. Kinoshita M, Kawamura M, Maeda T, Fujimaki Y, Fujita M, Kojima K, Teramoto T (2000) Apolipoprotein E accelerates the efflux of cholesterol from macrophages: mechanism of xanthoma formation in apolipoprotein E deficiency. J Atheroscler Thromb 6:22–27CrossRefGoogle Scholar
  11. Kulig W, Cwiklik L, Jurkiewicz P, Rog T, Vattulainen I (2016) Cholesterol oxidation products and their biological importance. Chem Phys Lipids 199:144–160CrossRefGoogle Scholar
  12. Latasa MJ, Moon YS, Kim KH, Sul HS (2000) Nutritional regulation of the fatty acid synthase promoter in vivo: sterol regulatory element binding protein functions through an upstream region containing a sterol regulatory element. Proc Natl Acad Sci USA 97:10619–10624CrossRefGoogle Scholar
  13. Li Y, Bolten C, Bhat BG, Woodring-Dietz J, Li S, Prayaga SK, Xia C, Lala DS (2002) Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism. Mol Endocrinol 16:506–514PubMedGoogle Scholar
  14. Ma Y, Xu L, Rodriguez-Agudo D, Li X, Heuman DM, Hylemon PB, Pandak WM, Ren S (2008) 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway. Am J Physiol Endocrinol Metab 295:E1369–E1379CrossRefGoogle Scholar
  15. Magaña MM, Osborne TF (1996) Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. J Biol Chem 271:32689–32694CrossRefGoogle Scholar
  16. Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V, Kreusch A, Saez E (2007) The nuclear receptor LXR is a glucose sensor. Nature 445:219–223CrossRefGoogle Scholar
  17. Paniangvait P, King AJ, Jones AD, German BG (1995) Cholesterol oxides in foods of animal origin. J Food Sci 60:1159–1174CrossRefGoogle Scholar
  18. Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, Guertin DA, Madden KL, Carpenter AE, Finck BN, Sabatini DM (2011) mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146:408–420CrossRefGoogle Scholar
  19. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, Griffiths JR, Chung YL, Schulze A (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8:224–236CrossRefGoogle Scholar
  20. Radhakrishnan A, Ikeda Y, Kwon HJ, Brown MS, Goldstein JL (2007) Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci USA 104:6511–6518CrossRefGoogle Scholar
  21. Sato M, Shirouchi B (2012) Physiological significance of oxidized cholesterols. Oleoscience 12:115–123 (Article in Japanese) CrossRefGoogle Scholar
  22. Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168:960–976CrossRefGoogle Scholar
  23. Schroepfer GJ Jr (2000) Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80:361–554CrossRefGoogle Scholar
  24. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, Shan B (2000) Role of LXRs in control of lipogenesis. Genes Dev 14:2831–2838CrossRefGoogle Scholar
  25. Shimano H, Sato R (2017) SREBP-regulated lipid metabolism: convergent physiology—divergent pathophysiology. Nat Rev Endrocrinol 13:710–730CrossRefGoogle Scholar
  26. Shirouchi B, Furukawa Y, Nakamura Y, Kawauchi A, Imaizumi K, Oku H, Sato M (2019) Inhibition of Niemann-Pick C1-like 1 by ezetimibe reduces dietary 5β,6β-epoxycholesterol absorption in rats. Cardiovasc Drugs Ther 33:35–44CrossRefGoogle Scholar
  27. Smith LL, Kulig MJ, Miiller D, Ansari GAS (1978) Sterol metabolism. 44. Oxidation of cholesterol by dioxygen species. J Am Chem Soc 100:6206–6211CrossRefGoogle Scholar
  28. Sottero B, Gamba P, Gargiulo S, Leonarduzzi G, Poli G (2009) Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry. Curr Med Chem 16:685–705CrossRefGoogle Scholar
  29. Starkov AA, Dedukhova VI, Skulachev VP (1994) 6-Ketocholestanol abolishes the effect of the most potent uncouplers of oxidative phosphorylation in mitochondria. FEBS Lett 355:305–308CrossRefGoogle Scholar
  30. Starkov AA, Bloch DA, Chernyak BV, Dedukhova VI, Mansurova SE, Severina II, Simonyan RA, Vygodina TV, Skulachev VP (1997) 6-Ketocholestanol is a recoupler for mitochondria, chromatophores and cytochrome oxidase proteoliposomes. Biochim Biophys Acta 1318:159–172CrossRefGoogle Scholar
  31. Sul HS, Wang D (1998) Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu Rev Nutr 18:331–351CrossRefGoogle Scholar
  32. van de Bovenkamp P, Kosmeijer-Schuil TG, Katan MB (1988) Quantification of oxysterols in Dutch foods: egg products and mixed diets. Lipids 23:1079–1085CrossRefGoogle Scholar
  33. Vejux A, Lizard G (2009) Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med 30:153–170CrossRefGoogle Scholar
  34. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033–1045CrossRefGoogle Scholar
  35. Xu L, Bai Q, Rodriguez-Agudo D, Hylemon PB, Heuman DM, Pandak WM, Ren S (2010) Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate. Lipids 45:821–832CrossRefGoogle Scholar
  36. Yamauchi Y, Furukawa K, Hamamura K, Furukawa K (2011) Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen. Cancer Res 71:4989–4997CrossRefGoogle Scholar
  37. Yanai H (2015) Statcel 4—the useful add-in software forms on Excel, 4th edn. OMS, TokyoGoogle Scholar
  38. Zarrouk A, Vejux A, Mackrill J, O’Callaghan Y, Hammami M, O’Brien N, Lizard G (2014) Involvement of oxysterols in age-related diseases and ageing processes. Ageing Res Rev 18:148–162CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2020

Authors and Affiliations

  • Bungo Shirouchi
    • 1
  • Shuhei Yanagi
    • 1
  • Chinami Okawa
    • 1
  • Maiko Koga
    • 1
  • Masao Sato
    • 1
    Email author
  1. 1.Laboratory of Nutrition Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate SchoolKyushu UniversityFukuokaJapan

Personalised recommendations